837408-71-6

Basic information

• Product Name: 4-BROMO-3-(ETHOXYMETHYL)BENZALDEHYDE
• Synonyms: 4-BROMO-3-(ETHOXYMETHYL)BENZALDEHYDE
• CAS NO: 837408-71-6
• Molecular Formula: C₁₀H₁₁BrO₂
• Molecular Weight: 243.09714
• Mol File: 837408-71-6.mol
• Article Data: 3

Chemical Properties

• Boiling Point: 303.8 °C at 760 mmHg
• Flash Point: 137.5 °C
• Appearance: /
• Density: 1.405 g/cm³
• Storage Temp.: 2-8°C
• CAS DataBase Reference: 4-BROMO-3-(ETHOXYMETHYL)BENZALDEHYDE(CAS DataBase Reference)
• NIST Chemistry Reference: 4-BROMO-3-(ETHOXYMETHYL)BENZALDEHYDE(837408-71-6)
• EPA Substance Registry System: 4-BROMO-3-(ETHOXYMETHYL)BENZALDEHYDE(837408-71-6)

Safety Data

• Hazardous Substances Data: 837408-71-6(Hazardous Substances Data)

Usage

General Description

4-Bromo-3-(ethoxymethyl)benzaldehyde is a chemical compound with the molecular formula C10H11BrO2. It is a brominated benzaldehyde derivative with an ethoxymethyl group attached to the aromatic ring. 4-BROMO-3-(ETHOXYMETHYL)BENZALDEHYDE is primarily used as an intermediate in the synthesis of pharmaceuticals and agrochemicals. It is also utilized as a reagent in organic chemistry, particularly in the preparation of various organic compounds. Additionally, 4-Bromo-3-(ethoxymethyl)benzaldehyde has potential applications in the fragrance and flavor industry. As with any chemical, it is important to handle and use this compound with proper safety precautions and in accordance with established protocols.

Upstream product

• 41963-20-6 4-bromo-3-methylbenzonirtile 
• 837408-81-8 4-bromo-3-(ethoxymethyl)benzonitrile 

Downstream Products

• 1026355-73-6 4'-[(2-butyl-4-oxo-1,3-diazaspiro[4.4]non-1-en-3-yl)methyl-N-](4,5-dimethyl-3-isoxazolyl)-2'-(ethoxymethyl)-N-(methoxymethyl) [1,1'-biphenyl]-2-sulfonamide 
• 254740-64-2 4'-[(2-butyl-4-oxo-1,3-diazaspiro[4.4]non-1-en-3-yl)methyl]-N-(4,5-dimethyl-3-isoxazolyl)-2'-(ethoxymethyl) [1,1'-biphenyl]-2-sulfonamide 

Relevant articles and documents

A BIPHENYLSULFONAMIDE ENDOTHELIN AND ANGIOTENSIN II RECEPTOR ANTAGONIST TO TREAT GLOMERULOSCLEROSIS

Methods of administering and pharmaceutical compositions of a biphenyl sulphonamide compound which is a dual angiotensin and endothelin receptor antagonist are disclosed for treating diseases.

Discovery of 4'-[(imidazol-1-yl)methyl]biphenyl-2-sulfonamides as dual endothelin/angiotensin II receptor antagonists.

A series of 4'-[(imidazol-1-yl)methyl]biphenylsulfonamides has potent antagonist activity against both angiotensin II AT(1) and endothelin ET(A) receptors. Such dual-acting antagonists could have utility in the treatment of hypertension, heart failure, an